Skip to main content

Pa. Judge Tosses Essure Birth Control Suits As Time-barred

Pa. Judge Tosses Essure Birth Control Suits As Time-barred

Pa. Judge Tosses Essure Birth Control Suits As Time-barred

Introduction

U.S. District Judge John Padova dismissed numerous claims brought by plaintiffs who sued Bayer over Essure birth control device's complications finding that the claims were not filed within the two-year statute of limitations.

Bayer had filed a summary judgment motion to toss 12 claims filed by affected women. In his opinion, Judge Padova evaluated those 12 cases over the device's hazards and ruled that many of the claims must be tossed at the summary judgment phase. Plaintiffs who discovered their alleged Essure-related injuries outside the two-year timeframe were allowed to pursue their tort claims past the summary judgment phase. Judge Padova dismissed those plaintiffs' claims that Bayer breached its warranty to provide permanent birth control; these plaintiffs did not become pregnant; or claimed that the device migrated; nor have they removed Essure device. According to Wednesday's ruling, Judge Padova allowed six women to pursue their claims as they had presented sufficient evidence to support their suspected injuries including pain, bleeding and autoimmune disorders caused by Essure; two of the women became pregnant despite using Essure.

All Essure lawsuits are consolidated under Judicial Council Coordination Proceedings (JCCP) before Judge Winifred Y. Smith of the Alameda County Superior Court.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!